IL159526A0 - Use of corticotroph-derived glycoprotein hormone to induce lipolysis - Google Patents
Use of corticotroph-derived glycoprotein hormone to induce lipolysisInfo
- Publication number
- IL159526A0 IL159526A0 IL15952602A IL15952602A IL159526A0 IL 159526 A0 IL159526 A0 IL 159526A0 IL 15952602 A IL15952602 A IL 15952602A IL 15952602 A IL15952602 A IL 15952602A IL 159526 A0 IL159526 A0 IL 159526A0
- Authority
- IL
- Israel
- Prior art keywords
- corticotroph
- glycoprotein hormone
- derived glycoprotein
- induce lipolysis
- lipolysis
- Prior art date
Links
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 210000001257 corticotroph Anatomy 0.000 title 1
- 230000003131 corticotrophic effect Effects 0.000 title 1
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 230000004130 lipolysis Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30528401P | 2001-07-13 | 2001-07-13 | |
| PCT/US2002/022747 WO2003006051A1 (en) | 2001-07-13 | 2002-07-15 | Use of corticotroph-derived glycoprotein hormone to induce lipolysis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL159526A0 true IL159526A0 (en) | 2004-06-01 |
Family
ID=23180168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15952602A IL159526A0 (en) | 2001-07-13 | 2002-07-15 | Use of corticotroph-derived glycoprotein hormone to induce lipolysis |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20030095983A1 (https=) |
| EP (1) | EP1414485A1 (https=) |
| JP (1) | JP2004521952A (https=) |
| CA (1) | CA2454181A1 (https=) |
| IL (1) | IL159526A0 (https=) |
| WO (1) | WO2003006051A1 (https=) |
| ZA (1) | ZA200400060B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030059877A1 (en) * | 2000-01-18 | 2003-03-27 | Sietse Mosselman | Human cystine knot polypeptide |
| CA2487924A1 (en) * | 2002-06-10 | 2003-12-18 | Zymogenetics, Inc. | Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| JP2007513191A (ja) * | 2003-12-05 | 2007-05-24 | ザイモジェネティクス，インコーポレイティド | 甲状腺刺激ホルモンを用いての炎症の処理方法 |
| CA2555908A1 (en) * | 2004-03-05 | 2005-09-22 | Zymogenetics, Inc. | Use of corticotroph-derived glycoprotein hormone to treat liver steatosis |
| JP5118292B2 (ja) * | 2005-06-16 | 2013-01-16 | 株式会社ロッテ | 脂肪分解促進剤 |
| US20070014736A1 (en) * | 2005-06-29 | 2007-01-18 | Okada Shannon L | Methods of delivering corticotroph-derived glycoprotein hormone |
| DK1971361T3 (da) | 2005-12-23 | 2014-09-08 | James D Kelly | Forbedrede glycoformer af thyroidstimulerende hormonreceptor-polypeptidagonist til behandling af metabolisk syndrom |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE336577T1 (de) * | 1998-02-13 | 2006-09-15 | Zymogenetics Inc | Protein, welches durch einen cystinknoten charakterisiert ist und verfahren zu dessen herstellung |
| WO2000078964A1 (en) * | 1999-06-17 | 2000-12-28 | Amgen Inc. | Glycoprotein hormone family member |
| US20020068279A1 (en) * | 1999-12-06 | 2002-06-06 | Curagen Corporation | Novel Proteins and nucleic acids encoding the same |
| US7514239B2 (en) * | 2000-03-28 | 2009-04-07 | Amgen Inc. | Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof |
| US20040005554A1 (en) * | 2000-05-08 | 2004-01-08 | Tayar Nabil El | Novel glycoproteins and methods of use thereof |
-
2002
- 2002-07-15 CA CA002454181A patent/CA2454181A1/en not_active Abandoned
- 2002-07-15 IL IL15952602A patent/IL159526A0/xx unknown
- 2002-07-15 WO PCT/US2002/022747 patent/WO2003006051A1/en not_active Ceased
- 2002-07-15 EP EP02748192A patent/EP1414485A1/en not_active Withdrawn
- 2002-07-15 JP JP2003511857A patent/JP2004521952A/ja active Pending
- 2002-07-15 US US10/196,437 patent/US20030095983A1/en not_active Abandoned
-
2004
- 2004-01-06 ZA ZA200400060A patent/ZA200400060B/en unknown
-
2005
- 2005-10-19 US US11/253,881 patent/US20060035818A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004521952A (ja) | 2004-07-22 |
| ZA200400060B (en) | 2004-08-17 |
| WO2003006051A1 (en) | 2003-01-23 |
| US20060035818A1 (en) | 2006-02-16 |
| US20030095983A1 (en) | 2003-05-22 |
| CA2454181A1 (en) | 2003-01-23 |
| EP1414485A1 (en) | 2004-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0103973D0 (en) | Improvements relating to skin prickers | |
| IL208892A0 (en) | Use of hmg fragment as anti-inflammatory agents | |
| EP1404343A4 (en) | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | |
| AU2002364893A8 (en) | Delivery of medicaments to the nail | |
| GB0103977D0 (en) | Improvements relating to skin prickers | |
| IL160928A0 (en) | Use of histamine to treat liver disease | |
| HRP20030874A2 (en) | Cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| PL373759A1 (en) | Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases | |
| EP1399175A4 (en) | THERAPEUTIC USE OF RANK ANTAGONISTS | |
| IL159526A0 (en) | Use of corticotroph-derived glycoprotein hormone to induce lipolysis | |
| HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
| TW577324U (en) | Improved structure of auxiliary walker | |
| HUP0401589A3 (en) | New peptides - analogs of human growth hormone-releasing hormone | |
| AU2003220201A8 (en) | Purification and cloning of nmn adenylyltranserase and its therapeutic use | |
| GB0222338D0 (en) | Surface treatment of concrete | |
| TW423322U (en) | Improved structure of massage pad | |
| EP1451308A4 (en) | THERAPEUTIC USE OF AZIRIDINO COMPOUNDS | |
| TW552926U (en) | Improved structure of thermal dressing bag | |
| PL347347A1 (en) | Apparatus enabling paraparesic persons to walk | |
| TW507567U (en) | Improved structure of gloves for shower use | |
| TW497384U (en) | Improved structure of baby blanket | |
| TW423321U (en) | Improved structure of multifunctional massage pad | |
| TW406718U (en) | Hand grip structure improvement of screed | |
| TW459847U (en) | Structure of anti-quake fastening piece for stone | |
| GB0129049D0 (en) | Improvements to self-sterilisation of surfaces |